Lymphoma Clinical Trials & Research

The modern treatment of Lymphoma is the result of well-planned and well-conducted international clinical trials (trials) with the participation of healthy volunteers and patients. Clinical trials are preceded by the synthesis of new molecules and compounds, a deep study of them in laboratories with the participation of animals.

Israel, along with many other countries, in full compliance with approved international standards and national legislation, is actively involved in conducting clinical trials, improving the treatment of Lymphoma. At clinical centres throughout hospitals, experienced and highly qualified doctors provide patients with a real opportunity to test new investigational drugs from leading pharmaceutical companies for free, compared to the use of modern drugs at the global level.

Clinical trials at Tel Aviv Medical Clinic

Our Israeli clinic employs experienced specialists who have been conducting clinical trials and studying the causes of Lymphoma for more than 10 years. Our department is equipped with modern equipment that helps to study human gene mutations. The clinic staff annually undergoes special training and improves their qualifications in international research centres. 

Clinical trials are studies that involve humans. Experts have noticed that blood cancer most often occurs as a result of gene mutations. There is a need to identify these genetic variations and customize treatment options based on the genetic characteristics of the Lymphoma cells. There are several ongoing multi-centre studies around the world in which patients are asked to donate samples of blood and bone marrow so these can be analyzed and stored for future study.

New Drugs and Treatment Regimens

Researchers are trying to find more effective and safer treatments for AML. They are studying new drugs, as well as existing drugs are given in different doses and with different methods of delivery (such as liposomal encapsulation). In the last 10 years, improvements in overall survival of AML patients have been driven by advances in the understanding of the genetics of the disease, as well as finding new ways to use existing medications. Researchers are continuing to modify and reformulate traditional chemotherapy drugs to improve overall survival. They are also evaluating combinations of chemotherapy drugs with newer targeted therapies. Treatment approaches under investigation include:

• Targeted therapy;
• Immunotherapy.